Hôpital Estaing - CHU de Clermont-Ferrand

Clermont-Ferrand 6 trials 1 recruiting

6 Registered trials

1 Currently recruiting

Organisation

Hôpital Estaing - CHU de Clermont-Ferrand

Location

Clermont-Ferrand, France

Identifier

ORL-000008592

Address

1 Rue Lucie et Raymond Aubrac, 63003, France

Departments

Digestive Oncology
Hématologie
Hépato-Gastroentérologie
Médecine Interne
Oncologie

Clinical trials at this site (6)

Search interface

Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI mCRC. (NIPISAFE) Pending

2024-518138-10-00 Patients with DMMR and/or MSI metastatic colorectal can 4
Maintenance With OSE2101 Plus FOLFIRI, or FOLFIRI After FOLFIRINOX-based Induction Therapy in Locally Advanced or Metastatic Pancreatic Duct… Pending

2024-518139-12-00 locally advanced or metastatic Pancreatic ductal adenoc 4
Efficacy and safety of bezafibrate 400 mg and bezafibrate 200 mg as adjunctive treatments in patients with primary biliary cholangitis and n… Recruiting

2023-504086-23-00 Subjects with PBC with a non-optimal response to UDCA. 5 2025-03-27
Loc-R01: Randomized Phase IB/II Study of escalating doses of Lenalidomide and Ibrutinib in association with R-MPV as a targeted induction tr… Ended

2024-515331-30-00 Primary Central Nervous System Lymphoma (PCNSL) 7 2020-10-30
Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations Ended

2024-514904-14-00 Patients with metastatic or unresectable locally advanc 4 2014-10-08
Salvage Therapy for Patients with Inadequate Response to Standard of Care Therapy in Granulomatosis with Polyangiitis Halted

2024-516687-28-00 Patients with GPA and inadequate response to standard o 5 2025-06-06